BioCentury
ARTICLE | Company News

Apollon, Biogen deal

December 8, 1997 8:00 AM UTC

Apollon received a license to BGEN's DNA sequences that encode hepatitis B viral antigens. BGEN retains the right to grant a limited number of other licenses to the technology. BGEN will purchase 83,3...